Alex M. Cranberg

Aspect Holdings LLC provides investments in oil and gas exploration companies. It engages in exploration and production activities in a number of countries, including the United States, Hungary, and the Kurdistan Region of Iraq. The company was founded by Alex Cranberg in 1993 and is headquartered Denver, CO.

Part of Aspect Energy LLC (Colorado), Hungarian Horizon Energy Ltd. is a company that engages in exploring gas. The company is based in Budapest, Hungary. The CEOs are Robert Todd Neugebauer, Alex M. Cranberg. The company was founded by Ibolya Ernyey.

Part of The University of Texas at Austin, The Board of Regents of The University of Texas System oversees college activities. The company is based in Austin, TX.

Aspect Energy LLC operates as an exploration and energy investment company. The firm is engaged in oil and gas exploration and development efforts. The company was founded in 1992 and is headquartered in Denver, CO.

QA Global GP LLC provides investment advisory services. The private company is based in Houston, TX. The CEO of the company is Alan L. Smith.

OneMap Mineral Services LLC engages in the minerals acquisition. The company was founded in 2012 and is headquartered in Houston, TX.

Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino.

Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan.